Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Severe Adverse Reaction to Vemurafenib in a Pregnant Woman with Metastatic Melanoma

Targeted therapies have drastically changed the management of metastatic melanoma and have shown encouraging results on tumour progression but are also known for their high rates of adverse reactions. In general, targeted therapies are contraindicated during pregnancy due to concerns about teratogen...

Full description

Bibliographic Details
Main Authors: Jorine de Haan, Johannes V. van Thienen, Michael Casaer, Rebekka A. Hannivoort, Kristel Van Calsteren, Minke van Tuyl, Mathilde M. van Gerwen, Anne Debeer, Frédéric Amant, Rebecca C. Painter
Format: Article
Language:English
Published: Karger Publishers 2018-02-01
Series:Case Reports in Oncology
Subjects:
Vemurafenib
Pregnancy
Metastatic melanoma
Toxic epidermal necrolysis
Online Access:https://www.karger.com/Article/FullText/487128

Internet

https://www.karger.com/Article/FullText/487128

Similar Items